688358 祥生医疗
2024/09 - 九个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)7.17110.9218.2729.2258.430
总资产报酬率 ROA (%)6.3309.6487.2698.1877.548
投入资产回报率 ROIC (%)7.00710.6498.0498.9278.008

边际利润分析
销售毛利率 (%)59.15358.80759.28456.29158.579
营业利润率 (%)29.78433.52830.23131.42932.659
息税前利润/营业总收入 (%)25.83428.61922.82632.29335.943
净利润/营业总收入 (%)27.16630.27527.79228.27329.912

收益指标分析
经营活动净收益/利润总额(%)89.48185.94877.59552.54762.216
价值变动净收益/利润总额(%)4.6908.34910.96514.07224.410
营业外收支净额/利润总额(%)-0.221-0.018-0.001-0.3912.447

偿债能力分析
流动比率 (X)7.0379.6927.1049.0919.847
速动比率 (X)6.3588.7106.0598.3809.195
资产负债率 (%)13.29510.07713.23810.90711.611
带息债务/全部投入资本 (%)1.4821.2641.7661.737--
股东权益/带息债务 (%)6,598.8547,725.4705,511.7055,598.3186,352.298
股东权益/负债合计 (%)652.172892.369655.383816.839761.272
利息保障倍数 (X)-6.651-5.836-3.08332.73714.578

营运能力分析
应收账款周转天数 (天)124.69092.287108.388118.5010.000
存货周转天数 (天)248.041300.633344.073190.0070.000